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with over 70percent healing rate. The current data lacks level 1 evidence.
Methodologically sound randomised controlled trials to compare against
split thickness skin graft are necessary.http://dx.doi.org/10.1016/j.ijsu.2016.08.315
0141: GIANT CELL TUMOURS OF TENDON SHEATH; A 10-YEAR EXPERI-
ENCE FROM MANCHESTER
B. Baker*, R. Murphy, A. Mishra. University Hospital South Manchester,
Manchester, UK.
Introduction: Giant cell tumours of tendon sheath (GCTTS) often
masquerade as other tumour-like lesions. Incomplete excision is thought
to contribute to recurrence; rates range from 5-45%. We aimed to evaluate
the role of imaging, completeness of excision, and recurrence rates.
Method: Consecutive patients from 2005-2015 with a histopathological
diagnosis of GCTTS in the upper limb were identiﬁed retrospectively from
our coded online reporting system. Demographic data, clinical diagnosis,
macro- and microscopic, and radiological tumour characteristics were
recorded.
Result: 47 patients(49 GCTTS) were identiﬁed; median age 49 years(IQR
34-64). The most common site was the index ﬁnger(18,37%) vs
thumb(10,20%), middle ﬁnger(10,20%), little ﬁnger(5,10%), and lesions
proximal to the MCPJs(5,10%). The mean maximum dimension was
15mm(SD 7). 18(37%) GCTTS were imaged, including plain radio-
graphs(12,24%), ultrasound(10,20%), andMRI(5,10%). 4(40%) were reported
by ultrasound as GCTTS vs 3(60%) by MRI. Diagnosis prior to histology was
correctly GCTTS in 30(61%) vs mucous cyst(6,12%), ganglion(5,10%),
gout(2,4%), and other(6,12%). Excision margins were clear in 25(51%) tu-
mours and indeterminate in 24(49%). None had malignant features. The
recurrence rate was 10%(5).
Conclusion: Recurrence rates were low despite half of GCTTS being
excised with indeterminate excision margins. Imaging was valuable for
operative planning in some cases, but not for diagnosis.http://dx.doi.org/10.1016/j.ijsu.2016.08.316
0146: BILATERAL V TO Y INFERIOR GLUTEAL ARTERY PERFORATOR
(IGAP) FLAPS FOR ABDOMINOPERINEAL (AP) RECONSTRUCTION
R. Rollett*, R. Clancy, A. Gargan, J. Wiper. Leeds General Inﬁrmary, Leeds, UK.
Introduction: More radical excisional surgery, especially for those with
recurrences has resulted in large perineal defects. For laparoscopic assisted
abdominoperineal (AP) resection, keeping the reconstruction outside the
abdominal cavity is a sensible option. Inferior Gluteal Artery Perforator
(IGAP) ﬂaps are a reliable and easy method of reconstruction following AP
resection for rectal tumours.
Method: Five patients had ten IGAP ﬂaps for AP reconstruction. Bilateral V
to Y perforator based ﬂaps were performed were performed with pt prone.
The medial portion of each IGAPwere de-epithelised and sutured together
then advanced into the defect. At least a 6cm advancement was achieved
from each side to obliterate the dead space.
This technique allows the natal cleft to remain in the midline in contrast to
unilateral IGAPs. No violation of anterior abdominal wall is required, unlike
a VRAM.
Result: There were no ﬂap failures, partial loss or wound dehiscence.
Reconstructive operating time was less than 60 minutes.
Conclusion: The use of the IGAP ﬂap prevents interference of stoma sites
and further insult to the abdominal wall. This shortens recovery time, we
conclude that IGAP ﬂaps are a reliable, technically easy and a quickmethod
of reconstruction following AP resection for low rectal tumours.http://dx.doi.org/10.1016/j.ijsu.2016.08.317
0278: REORGANISATION OF CRANIOFACIAL SERVICES WITHIN NORTH
WEST THAMESA. Plonczak*, L. Ioannidi, C. Abela. Chelsea and Westminster Hospital Trust,
London, UK.
Aim: Merging West Middlesex and Chelsea and Westminster Hospital
Trusts provides an opportunity to streamline the pathway for patients
with facial trauma.
Method: We conducted a retrospective analysis of patients presenting to
West Middlesex Hospital Emergency.
Department with facial trauma between April 2014eMarch 2015.
Result: 64 patients were included (46 males, 18 females). There were 51
adults and 13 children. Facial fractures.
(30%) were the commonest sequelae of facial trauma, followed by dental
(25%) and soft tissue injuries (14%). 11 patients (17%) were referred with
clinically suspected facial fractures but normal plain x-rays. Themajority of
fractures were mandible (n¼9), then nasal (n¼2), orbital wall (n¼2),
mandible dislocation (n¼2) and fractures involving multiple facial bones
(n¼2). 85% of bony injuries were referred to a distant hospital and 80% of
soft tissue injuries were referred to the Chelsea and Westminster Hospital.
8 out of 27 patients with bony injuries referred externally were asked to
attend an eye review at a separate hospital prior to assessment at the
Craniofacial Unit.
Conclusion: We present data prior to re-organising craniofacial trauma
services within North West Thames. We aim to bring the management of
facial trauma into a semi-elective setting and provide a one-stop service.http://dx.doi.org/10.1016/j.ijsu.2016.08.3180394: TO CELLUTOME OR NOT TO CELLUTOME? A PATIENT REPORTED
OUTCOME MEASURE AND COST EVALUATION STUDY
S.J. Edmondson*, O. Smith, N. Bystrzonowski, N. Hachach-Haram,
M. Kanapathy, L. Twyman, T. Richards, A. Mosahebi. Royal Free NHS
Foundation Trust Hospital, London, UK.
Aim: Split-thickness skin grafts (SSGs) are a useful method for covering
defects. However, they require anaesthesia, access to specialist equipment
and stafﬁng and can have high donor site (DS) morbidity. The CelluTome
epidermal graft-harvesting device is an alternative, providing pain-free
epidermal-skin grafts (ESG) in outpatient settings with minimal DS
trauma. This study aims to compare ESG with SSG by evaluating patient-
related outcome measures (PROMs) and associated costs.
Method: Twenty patients answered a validated subjective skin graft
satisfaction questionnaire evaluating donor/graft site noticeability,
aesthetic concerns, adverse problems and patient satisfaction. Costs were
calculated for each group based on operative expenses and dressing clinic
appointments.
Result: Complete satisfaction with DS appearance was observed in 100% of
ESG cases compared with 50% of SSG cases. Noticeability, adverse prob-
lems and overall satisfaction were signiﬁcantly better in the ESG group
compared with the SSG group (p<0.05). Graft site parameters were com-
parable with similar healing outcomes. Cost/patient for ESG was £431 and
£1489 for SSG, resulting in annual savings of £126,960 based on ten cases/
month.
Conclusion: CelluTome provides comparable wound healing to traditional
SSGs, with reduced DS morbidity and higher patient satisfaction. More-
over, CelluTome facilitates the outpatient treatment of wounds whilest
substantially reducing costs.http://dx.doi.org/10.1016/j.ijsu.2016.08.319
0420: TOPICAL GLYCOPYRROLATE REDUCES AXILLARY HYPERHIDROSIS
TO A SIMILAR EXTENT AS SUBCUTANEOUS BOTOX INJECTIONS
A. Quddus*, R. Nicholas, D. Baker. Royal Free Hospital, London, UK.
Introduction: Axillary hyperhidrosis affects 3% of the population. Subcu-
taneous botulinum toxin A (Botox) is the current “Gold Standard” treat-
ment for severe cases. Conversely, the effectiveness of topical anti-
cholinergic solutions is unclear. This study compares the effectiveness of
